
The ongoing legal battle between Elon Musk and OpenAI creates significant governance risk, making secondary market shares of the private AI giant highly volatile. Investors in Microsoft (MSFT) should monitor the trial closely, as any court-ordered restructuring of OpenAI could jeopardize Microsoft’s multi-billion dollar strategic advantage in the AI arms race. Tesla (TSLA) shareholders must weigh "key person risk," as Musk’s focus on this $150 billion lawsuit and his competing venture, xAI, may distract from Tesla's core autonomous goals. For those with access to private markets, xAI represents the primary "for-profit" alternative to OpenAI, though it remains a high-risk play tied to Musk’s personal reputation. Given the massive capital requirements and increasing regulatory scrutiny, focus on established "money spigots" like Microsoft while bracing for sector-wide volatility driven by these high-stakes leadership disputes.

By The New York Times
This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro, Rachel Abrams and Natalie Kitroeff. Twenty minutes a day, five days a week, ready by 6 a.m. Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. Listen to this podcast in New York Times Audio, our new iOS app for news subscribers. Download now at nytimes.com/audioapp